Poland· PL-100245425

Ceftazidime Kabi

A ceftazidime product containing ceftazidimum, registered in Poland by Fresenius Kabi Polska Sp. z o.o.. The same ATC class is registered in 18 of our 19 countries.

ATC J01DD02

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ceftazidimumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ceftazidime is registered in 18 of 19 countries.

Countries holding a registration under ATC J01DD02 (ceftazidime), each read from that country’s own register.

This record: Poland, from URPL (Poland)
10 of them publish a price we can compare per daily dose

Search ceftazidime products by name

Ceftazidime · ATC J01DD02

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ceftazidime costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ceftazidime · price per daily dose (4 g)

USD · FX 28 Sept 2026

CH Switzerland$129.98

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Ceftazidimum
Manufacturer: Fresenius Kabi Polska Sp. z o.o.
Country: Poland (PL)
ATC code: J01DD02
ATC class: Ceftazidime
Defined daily dose: 4 g, P
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 2

gtin
05909990860487
gtin
05909990860494

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

155 interactions on record for ceftazidime.

Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ceftazidime against other medicines How interaction checks work

Ceftazidime · interactions on record

155 records

34 moderate
121 info

Most severe, free to view

Sodium picosulfateA06AB08moderate
NeomycinA07AA01moderate
StreptomycinA07AA04moderate
Amphotericin BA07AA07moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ceftazidime in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ceftazidime products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Ceftazidim Aptapharma, Ceftazidim Hameln
Belgium · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
Bulgaria · Алфагем, Зидимцеф
Cyprus · Alfagem, Cezid
Czechia · Altecim, Ceftazidim Aptapharma
Germany · Ceftazidim Dr. Eberth, Ceftazidim Hameln
Denmark · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
Estonia · Altecim, Ceftazidime Fresenius Kabi
Spain · Alfagem, Ceftazidima Kabi
Finland · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
France · Ceftazidime Arrow, Ceftazidime Enfants Et Nourrissons Panpharma
United Kingdom (Northern Ireland) · Ceftazadime, Ceftazidime Cox Pharmaceutical
Greece · Alfagem, Ceftaridem
Croatia · Altecim, Cefaz
Hungary · Ceftazidim Aptapharma, Ceftazidim Kabi
Ireland · Ceftazidime Hameln, Ceftazidime Hikma Farmacêutica
Iceland · Ceftazidim Fresenius Kabi, Ceftazidima Normon
Italy · Ceftazidima Almus, Ceftazidima Astro-Pharma
Lithuania · Biotum, Ceftazidime Kabi
Luxembourg · Ceftazidim Fresenius Kabi, Glazidim
Latvia · Ceftazidime Fresenius Kabi, Ceftazidime Mip
Malta · Alfagem, Ceftazidima Fresenius
Netherlands · Ceftazidim (Im/Iv) Mip, Ceftazidim (Iv) Mip
Norway · Ceftazidim Fresenius Kabi, Ceftazidim Hameln
Portugal · Alfagem, Ceftazidima Accord
Romania · Alfagem, Ceftamil
Sweden · Ceftazidim Hameln, Fortum
Slovenia · Ceftazidim Aptapharma, Ceftazidim Kabi
Slovakia · Ceftazidim Ash, Ceftazidim Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/42e82821-cef9-4ca6-8d8c-8a4f012494d0
GET /v1/drugs/42e82821-cef9-4ca6-8d8c-8a4f012494d0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "1000 mg",
  "packaging": "05909990860487 ¦ Lz ¦ 65749\n1 fiol. \n05909990860494 ¦ Lz ¦ 65861\n10 fiol.",
  "substance": "Ceftazidimum 1164.8 mg",
  "common_name": "Ceftazidimum",
  "pl_product_id": "100245425",
  "pozwolenie_nr": "18085",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about ceftazidime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console